Pulmonary involvement in unusual multisystem disorders

Current Opinion in Pulmonary Medicine

Volumn 3, Issue 5, 1997, Pages 384-390

  Chanana, Anjali ^a   Sharma, Om P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; MALE; REVIEW;

FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE;

EID: 0031228041     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199709000-00012     Document Type: Article

References (43)

1. Kyle RA, Gertz MA: Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995, 32:45-49.
2. Merlini G: Treatment of primary amyloidosis. Semin Hematol 1995, 32:60-79.
3. Sharma O, Koss M, Buck F: Sarcoidosis and amyloidosis: is the association causal or coincidental? Sarcoidosis 1987, 4:139-141.
4. Utz J, Swensen S, Gertz M: Pulmonary amyloidosis: the Mayo Clinic experience from 1980 to 1993. Ann Intern Med 1996, 124:407-413. An outstanding review describing the diagnosis, prognosis, chest roentgenographic presentation, and clinical features of 35 patients with pulmonary amyloidosis, which can be diagnosed by bronchoscopic lung biopsy with reasonable safety.
5. Kanada DJ, Sharma OP: Long-term survival with diffuse interstitial pulmonary amyloidosis. Am J Med 1979, 67:879-882.
6. Case Records of the Massachusetts General Hospital: Case #23-1996. N Engl J Med 1996, 335:266-273.
7. Bontemps F, Tillie-Leblond I, Coppin M, Frehart P, Wallaert B, Ramon P, Tonnel A: Pleural amyloidosis: thoracoscopic aspects. Eur Respir J 1995, 8:1025-1027.
8. Cohen AS, Jones LA: Amyloid and amyloidosis. Curr Opin Rheumatol 1992, 4:94-105.
9. Woo P: Amyloidosis in pediatric rheumatic diseases. J Rheumatol 1992, 35(suppl):10-16.
10. Skinner M, Anderson J, Simms R, Falk R, Wang M, Libbey C, Jones L, Cohen A: Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalen, prednisone, and colchicine versus colchicine only. Am J Med 1996, 100:290-298.
11. Kikuchi M: Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytosis. Nippon Ketsueki Gakkai Zasshi 1972, 35:379-380.
12. Case Records of Massachusetts General Hospital: Case #5-1997. N Engl J Med 1997, 336:492-499.
13. Dilsen N, Cavdar T, Aral O, Konice M, Erkan F, Ocal L: Pulmonary involvement in Behçet's disease in Turkey. In Behçet's Disease: Basic and Clinical Aspects. Edited by O'Duffy DJ, Kokman E. New York: Marcel Dekker; 1991:195-204.
14. Efthimiou J, Johnston C, Spiro SG, Turner-Warwick M: Pulmonary disease in Behçet's syndrome. Q J Med 1986, 58:259-280.
15. Abadoglu O, Osma E, Ucan E, Cavdar C, Akkoc N, Kupelioglu O, Akbylar A: Behçet's disease with pulmonary involvement, superior vena cava syndrome, chyloptysis and chylous ascites. Resp Med 1996, 96:429-431.
16. Yasui K, Ohta K, Kobayashi M, Arizawa T, Korniyama A: Successful treatment of Behçet's disease with pentoxifylline. Ann Intern Med 1996, 124:891-893.
17. Whipple GH: A hitherto undescribed disease characterized by deposits of fat and fatty acids, in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp 1907, 18:382-391.
18. Symmons DPM, Shepherd AN, Boardman PL, Bacon P: Pulmonary manifestations of Whipple's disease. Q J Med 1985, 56:497-502.
19. Keren DF: "Whipple's disease": the causative agent defined, its pathogenesis remains obscure. Medicine 1993, 72:355-358.
20. Ramzan NN, Loflus E, Burgart L, Rooney M, Batts K, Weisner R, Fredrichs D, Relman D, Persing D: Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med 1997, 126:520-527.
21. Wiesenfeld D, Ferguson M, Mitchell D, MacDonald D, Scully C, Cochran K, Russell R: Orofacial granulomatosis: a clinical and pathological analysis. Q J Med 1985, 54:101-103.
22. Melkersson E: U fall au recidiverande facialispares. Hygiea 1928, 90:737-741.
23. Rosenthal C: Facialislahmung und lingua plicata. Z Neurol Psychol 1930, 131:475-501.
24. Sweet RD: An acute febrile neutrophilic dermatosis. Br J Dermatol 1964, 76:349-356.
25. Cohen PR, Holder WR: Sweet's syndrome in patients with solid tumor. Cancer 1993, 72:2723-2731.
26. Von den Dnesch P: Sweet's syndrome (acute febrile neutrophilic dermatoses). J Am Acad Dermatol 1994, 31:535-556.
27. Reid PT, Alderdice J, Carson J, Sinnamon D: Cryptogenic pneumonia in association with Sweet's syndrome. Resp Med 1996, 90:57-59.
28. Takimoto CH, Wamock M, Golden JA: Sweet's syndrome with lung involvement. Am Rev Respir Dis 1991, 143:177-179.
29. Burke SJ, Quinn AG, Farr PM, Ashcroft T, Gibson G: Neutrophilic alveolitis in Sweet's syndrome. Thorax 1992, 47:572-573.
30. Fukutoku M: Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anemia. Br J Hematol 1994, 86:645-648.
31. Johnson ML: Leukocyte colony-stimulating factors: a review of associated neutrophilic dermatoses and vasculitis. Arch Dermatol 1994, 130:77-81.
32. Davies PDB: Diffuse pulmonary involvement in von Recklinghausen's disease: a new syndrome. Thorax 1963, 18:198-200.
33. Massaro D, Katz S: Fibrosing alveolitis: its occurrence, roentgenographic, and pathologic features in von Recklinghausen's neurofibromatosis. Am Rev Resp Dis 1966, 93:934-942.
34. Webb WR, Goodman PC: Fibrosing alveolitis in patients with neurofibromatosis. Radiology 1977, 122:289-293.
35. Myer FJ, Teschler H, Schnabel R, Costabel U: Bronchoalveolar lavage cytology in pulmonary fibrosis associated with neurofibromatosis. Resp Med 1996, 90:365-367.
36. Riccardi VM: Mast cell stabilization to decrease neurofibroma growth. Arch Dermatol 1987, 123:1011-1015.
37. Patchefsky AS, Atkinson WG, Hoch WS, Gordon G, Lipshitz H: Interstitial pulmonary fibrosis in von Recklinghausen's disease: an ultrastructural and immunofluorescent study. Chest 1973, 64:459-464.
38. Zimran A, Kay Andrea, Gelbart T, Garver P, Thurston D, Saven A, Beutler E: Gaucher disease. Medicine 1993, 71:337-353.
39. Schneider EL, Epstein CJ, Kaback MJ, Brandes D: Severe pulmonary involvement in adult Gaucher's disease: report of three cases and review of the literature. Am J Med 1977, 63:474-488.
40. Kerem E, Elstein D, Abrahamov A, Ziv Y, Hadas-Halpern I, Melzer E, Cahan C, Branski D, Zimran A: Pulmonary function abnormality in type I Gaucher's disease. Eur Resp J 1996, 9:340-345.
41. Dawson A, Elias D, Rubenson D, Bartz D, Garver P, Kay A, Bloor C, Beutler E: Pulmonary hypertension developing after algucerase in two patients with type I Gaucher's disease complicated by the hepatopulmonary syndrome. Ann Intern Med 1996, 125:901-904.
42. Theise ND, Ursell PC: Pulmonary hypertension and Gaucher's disease: logical association or mere coincidence? Am J Pediatr Hematol Oncol 1990, 12:74-76.
43. Beutler E, Kay A, Sarven A, Garver P, Thurston D, Dawson A, Rosenbloom B: Enzyme replacement therapy for Gaucher's disease. Blood 1991, 78:1183-1189.